课题基金 / 基金详情

Biogenesis of Transport Vesicles Coated by COPI

Biogenesis of Transport Vesicles Coated by COPI
COPI 包被的运输囊泡的生物发生
批准号:
7211297
负责人:
VICTOR W HSU
金额:
$39.38万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2010-12-31

项目摘要

项目成果

VICTOR W HSU的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):阐明由Coat Protein I(COPI)复合体调控的细胞内转运机制,我们发现GTP酶激活蛋白(GAP)for the Small GTP aseADP-RiBosylating Factor“!(ARF1)不仅作为ARF1的负性调节因子,而且通过作为涂层成分而作为其效应器。这一发现推翻了流行的观点,即间隙在COPI囊泡的脱壳中起作用,应该拮抗囊泡的形成,但与阐明的COPII囊泡形成机制一致,其中相应的间隙也被证明作为COPII包衣复合体的一个组成部分发挥作用。最近,我们对COPI囊泡重建系统进行了改进,我们揭示了这个过程需要辅助蛋白,这类似于已被证明使用多种辅助蛋白的网状蛋白囊泡的形成。因此,由于COPI运输的关键机制现在似乎比先前怀疑的更类似于为其他特征良好的运输途径所阐明的机制,关键机制中的这种观察到的保守性也成为当前应用中的总体驱动假说,该应用试图进一步阐明COPI囊泡的形成和去涂层的机制。首先,由于我们已经发现GAP不直接触发COPI囊泡去涂层,我们将通过系统的纯化方法来确定预测的新的去涂层因子(S),并通过检测更好地解释分子筛蛋白囊泡的去涂层机制来补充这一策略。其次,正如我们最近发现的那样,Brefeldin-A ADP核糖化底物(BARS)和内亲和素B作为COPI囊泡形成的分裂机制的关键组件发挥着可互换的作用,我们将更准确地确定它们是如何实现这一作用的,这可能再次受到来自分裂机制的潜在线索的促进,这些线索已经被更好地解释用于网状蛋白囊泡。第三,我们确定了磷脂酶D(PLD)活性在COPI囊泡形成中的新作用。因此,我们将澄清这一角色,这也将解决目前关于该活动在COPI囊泡形成中的确切作用的争议。第四,我们将研究最近与ARFGAP1相互作用的安替奎因是否以及如何在COPI囊泡形成和/或货物分拣中发挥作用。我们预计,这些研究的完成不仅将进一步阐明COPI运输的机制,而且还将促进对囊泡运输的总体理解,因为关键机制可能在所有运输途径中都是保守的。因此,随着细胞内转运途径的缺陷被认为是导致越来越多的人类疾病的原因,我们的发现可能会广泛适用于理解和治疗这些疾病。
英文摘要
DESCRIPTION (provided by applicant): Elucidating mechanisms of intracellular transport regulated by the Coat Protein I (COPI) complex, we have found that the GTPase-activating protein (GAP) for the small GTPase ADP-Ribosylation Factor"! (ARF1) acts not only as a negative regulator of ARF1, but also as its effector by being a coat component. This finding reverses the prevailing view that the GAP functions in the uncoating of COPI vesicles and should antagonize vesicle formation, but is consistent with mechanisms elucidated for the formation of COPII vesicles, where the corresponding GAP has also been shown to function as a component of the COPII coat complex. Refining the COPI vesicle reconstitution system recently, we have revealed that this process requires accessory proteins, which is similar to the formation of clathrin vesicles that have been shown to use multiple accessory proteins. Thus, as key mechanisms of COPI transport now appear to be more similar to that elucidated for the other well-characterized transport pathways than previously suspected, this observed conservation in key mechanisms also becomes the overall driving hypothesis in the current application that seeks to further elucidate mechanisms of COPI vesicle formation and uncoating. First, as we have found that GAP does not directly trigger COPI vesicle uncoating, we will identify predicted novel uncoating factor(s) by a systematic purification approach and also complement this strategy by examining for potential clues from mechanisms of uncoating that are better elucidated for clathrin vesicles. Second, as we have found recently that Brefeldin-A ADP-Ribosylated Substrate (BARS) and endophilin B play interchangeable roles as key components of the fission machinery for COPI vesicle formation, we will determine more precisely how they achieve this role, which again will likely be facilitated by potential clues from mechanisms of fission that have been better elucidated for clathrin vesicles. Third, we have identified a novel role for phospholipase D (PLD) activity in COPI vesicle formation. Thus, we will clarify this role, which will also address a current controversy regarding the precise role of this activity in COPI vesicle formation. Fourth, we will examine whether and potentially how antiquitin, which we have shown recently to interact with ARFGAP1, plays a role in either COPI vesicle formation and/or cargo sorting. We anticipate that the completion of these studies will not only further elucidate mechanisms of COPI transport, but also advance a general understanding of vesicular transport, as key mechanisms are likely to be conserved across all transport pathways. Thus, as defects in intracellular transport pathways are being appreciated as the cause for a growing number of human diseases, our findings will likely be broadly applicable to understanding and treating these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of endocytic recycling
  • 批准号:
    10886202
  • 项目类别:
  • 资助金额:
    $1.5万
  • 财政年份:
    2023
  • 负责人:
    VICTOR W HSU
  • 依托单位:
Mechanisms of endocytic recycling
  • 批准号:
    10584055
  • 项目类别:
  • 资助金额:
    $41.71万
  • 财政年份:
    2023
  • 负责人:
    VICTOR W HSU
  • 依托单位:
Mechanisms of Endocytic Recycling
  • 批准号:
    9322098
  • 项目类别:
  • 资助金额:
    $9.0万
  • 财政年份:
    2015
  • 负责人:
    VICTOR W HSU
  • 依托单位:
Mechanisms of Endocytic Recycling
  • 批准号:
    9100794
  • 项目类别:
  • 资助金额:
    $41.48万
  • 财政年份:
    2015
  • 负责人:
    VICTOR W HSU
  • 依托单位:
海外基金